Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab-Reference-Cited by-同舟云学术

Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab

Published:2013-04-09 Issue:7 Volume:54 Page:1026-1031
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Skougaard Kristin,Nielsen Dorte,Jensen Benny Vittrup,Hendel Helle Westergren

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference39 articles.

1. Measuring Response with FDG-PET: Methodological Aspects

2. 18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours;De Maeseneer;Acta Clin Belg.,2010

3. Established, emerging and future roles of PET/CT in the management of colorectal cancer

4. Recommendations on the Use of 18F-FDG PET in Oncology

5. Monitoring chemotherapy and radiotherapy of solid tumors

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Lugano Criteria Versus RECIL and PERCIST as Prognostic Factors in Diffuse Large B-Cell Lymphoma;Clinical Nuclear Medicine;2024-01-24

2. Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer;Diagnostics;2023-04-28

3. Immunotherapy Assessment: A New Paradigm for Radiologists;Diagnostics;2023-01-13

4. Radioembolization-Induced Changes in Hepatic [18F]FDG Metabolism in Non-Tumorous Liver Parenchyma;Diagnostics;2022-10-17

5. Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study;Cancers;2021-08-23